NTRB - Nutriband Inc
IEX Last Trade
4.12
-0.130 -3.155%
Share volume: 41,979
Last Updated: Fri 30 Aug 2024 09:52:11 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$4.25
-0.13
-3.06%
View ratios
| Fiscal Date | 2022-07-31 | 2022-10-31 | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 | 2024-04-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 2022-09-08 | 2022-12-02 | 2023-04-26 | 2023-06-09 | 2023-09-11 | 2023-12-13 | 2024-05-01 | 2024-05-31 | |
| Assets | |||||||||
| Total Assets | 11.387 M | 10.669 M | 9.456 M | 8.676 M | 9.873 M | 8.523 M | 7.517 M | 15.154 M | |
| Current Assets | 4.114 M | 3.507 M | 2.694 M | 1.993 M | 3.274 M | 2.000 M | 1.022 M | 8.730 M | |
| Inventories | 161.830 K | 184.323 K | 229.335 K | 181.497 K | 156.921 K | 174.641 K | 168.605 K | 168.505 K | |
| Other Current Assets | 461.011 K | 426.105 K | 365.925 K | 369.279 K | 558.647 K | 390.104 K | 211.667 K | 128.551 K | |
| Short Term Investments | 461.011 K | 426.105 K | 365.925 K | 369.279 K | 558.647 K | 390.104 K | 211.667 K | 128.551 K | |
| Total Receivables | 146.557 K | 80.455 K | 113.045 K | 164.641 K | 223.452 K | 169.669 K | 148.649 K | 85.144 K | |
| Current Cash | 3.345 M | 2.816 M | 1.985 M | 1.278 M | 2.335 M | 1.265 M | 492.942 K | 8.348 M | |
| Total Non-current Assets | 7.273 M | 7.162 M | 6.763 M | 6.682 M | 6.599 M | 6.523 M | 6.495 M | 6.425 M | |
| Property Plant Equipment | 978.863 K | 933.642 K | 897.735 K | 853.445 K | 806.423 K | 766.839 K | 774.924 K | 740.305 K | |
| Other Assets | 83.210 K | 70.599 K | 62.754 K | 54.909 K | 47.064 K | 39.219 K | 31.374 K | 23.529 K | |
| Intangible Assets | 862.004 K | 808.718 K | 780.430 K | 752.143 K | 723.855 K | 695.568 K | 667.280 K | 638.993 K | |
| Goodwill | 5.349 M | 5.349 M | 5.022 M | 5.022 M | 5.022 M | 5.022 M | 5.022 M | 5.022 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 11.387 M | 10.669 M | 9.456 M | 8.676 M | 9.873 M | 8.523 M | 7.517 M | 15.154 M | |
| Total liabilities | 985.242 K | 937.633 K | 883.387 K | 955.821 K | 2.982 M | 2.812 M | 1.079 M | 1.791 M | |
| Total current liabilities | 803.924 K | 789.752 K | 748.613 K | 784.393 K | 874.127 K | 717.774 K | 999.093 K | 1.417 M | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 37.149 K | 51.921 K | 51.031 K | 51.943 K | 159.459 K | 160.417 K | 161.459 K | 153.407 K | |
| Long term debt | 181.318 K | 147.881 K | 134.774 K | 171.428 K | 2.108 M | 2.094 M | 79.826 K | 374.509 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 10.402 M | 9.732 M | 8.573 M | 7.720 M | 6.891 M | 5.711 M | 6.438 M | 13.363 M | |
| Common stock | 8.404 M | 6.689 M | 9.567 M | 7.833 M | 7.833 M | 7.833 M | 8.317 M | 9.160 M | |
| Retained earnings | -19.740 M | -20.815 M | -22.495 M | -23.510 M | -24.339 M | -26.099 M | -27.980 M | -29.878 M |